Pparg may Promote Chemosensitivity of Hypopharyngeal Squamous Cell Carcinoma
Open Access
- 22 April 2020
- journal article
- research article
- Published by Wiley in PPAR Research
- Vol. 2020, 1-6
Abstract
The upregulation of peroxisome proliferator-activated receptor gamma (PPARG) has been shown to increase the chemosensitivity of several human cancers. This study is aimed at studying if PPARG sensitizes hypopharyngeal squamous cell carcinoma (HSCC) in chemotherapeutic treatments and at dissecting possible mechanisms of observed effects. We integrated large-scale literature data and HSCC gene expression data to identify regulatory pathways that link PPARG and chemosensitivity in HSCC. Expression levels of molecules within the PPARG regulatory pathways were compared in 21 patients that underwent chemotherapy for primary HSCC, including 12 chemotherapy-sensitive patients (CSP) and 9 chemotherapy-nonsensitive patients (CNSP). In the CPS group, expression levels of PPARG were higher than that in the CNSP group (). Structured text mining identified two chemosensitivity-related regulatory pathways driven by PPARG. In the CSP group, expression levels for 7 chemosensitivity-promoting genes were increased, while for 13 chemosensitivity suppressing the gene expression levels were decreased. Our results support the chemosensitivity-promoting role of PPARG in HSCC tumor cells, most likely by affecting both cell proliferation and cell motility pathways.
Keywords
Funding Information
- Beijing Municipal Administration of Hospitals’ Ascent Plan (DFL20180202, 2018-2-205, Z141107002514003, QN2018-32, PX2018009)
- Capital Health Research and Development of Special (DFL20180202, 2018-2-205, Z141107002514003, QN2018-32, PX2018009)
- Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park (DFL20180202, 2018-2-205, Z141107002514003, QN2018-32, PX2018009)
- Beijing Administration of Traditional Chinese Medicine (DFL20180202, 2018-2-205, Z141107002514003, QN2018-32, PX2018009)
- Beijing Municipal Administration of Hospitals Incubating Program (DFL20180202, 2018-2-205, Z141107002514003, QN2018-32, PX2018009)
This publication has 19 references indexed in Scilit:
- Cancer Statistics for Hispanics/Latinos, 2018CA: A Cancer Journal for Clinicians, 2018
- Functional activation of PPARγ in human upper aerodigestive cancer cell linesMolecular Carcinogenesis, 2016
- Prognostic significance and therapeutic implications of peroxisome proliferator-activated receptor γ overexpression in human pancreatic carcinomaInternational Journal of Oncology, 2014
- PPARγ in head and neck cancer preventionOral Oncology, 2014
- Manganese Superoxide Dismutase Is a Promising Target for Enhancing Chemosensitivity of Basal-Like Breast CarcinomaAntioxidants & Redox Signaling, 2014
- Letter to the editors: Essentials for an updated epidemiology of laryngeal carcinomaCancer Treatment Reviews, 2012
- Regulatory role of KEAP1 and NRF2 in PPARγ expression and chemoresistance in human non-small-cell lung carcinoma cellsFree Radical Biology and Medicine, 2012
- Expression of peroxisome proliferator-activated receptor gamma and cyclooxygenase 2 in oral squamous cell carcinomaInternational Journal of Oral and Maxillofacial Surgery, 2009
- PPAR Activation and Decreased Proliferation in Oral Carcinoma Cells With 4‐HPROtolaryngology–Head and Neck Surgery, 2005
- Hypopharyngeal Cancer: Results of Treatment Based on Radiation Therapy and Salvage SurgeryThe Laryngoscope, 2002